Related Experiment Videos
Varicella pneumonia: another 'steroid responsive' pneumonia?
R Ahmed1, Q A A Ahmed, N A Adhami
1Department of Critical Care Medicine, King Fahad National Guard Hospital, Riyadh, Kingdom of Saudi Arabia.
Journal of Chemotherapy (Florence, Italy)
|May 23, 2002
Summary
Varicella-zoster virus (VZV) pneumonitis is a severe complication. Corticosteroids may be cautiously considered for life-threatening cases, but patient selection requires clinical judgment.
Area of Science:
- Infectious Diseases
- Pulmonology
- Virology
Background:
- Varicella-zoster virus (VZV) infection can lead to pneumonitis, a serious and potentially fatal lung complication.
- Current standard treatments for VZV pneumonitis include antiviral medications and supportive care.
Purpose of the Study:
- To evaluate the potential role and justification of corticosteroid therapy in managing severe cases of VZV pneumonitis.
- To highlight the clinical decision-making process for using corticosteroids in this context.
Main Methods:
- This is a conceptual or clinical review based on existing knowledge and practice.
- Discussion focuses on the risks and benefits of corticosteroid use in VZV pneumonitis.
Main Results:
- VZV pneumonitis is associated with high mortality.
- Cautious use of corticosteroids might be beneficial in life-threatening VZV pneumonitis.
- Specific criteria for patient selection for corticosteroid therapy are currently undefined.
Conclusions:
- The decision to use corticosteroids in VZV pneumonitis is primarily clinical.
- Further research is needed to identify appropriate patient selection factors for corticosteroid therapy.